US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 67.760
- +1.600+2.42%
Close Nov 15 16:00 ET
- 67.760
- 0.0000.00%
Post 20:02 ET
39.96BMarket Cap9.82P/E (TTM)
67.830High65.310Low7.53MVolume65.310Open66.160Pre Close507.46MTurnover1.29%Turnover Ratio29.46P/E (Static)589.80MShares96.12052wk High4.19P/B39.56BFloat Cap58.93052wk Low--Dividend TTM583.78MShs Float131.730Historical High--Div YieldTTM3.81%Amplitude1.000Historical Low67.391Avg Price1Lot Size
Edwards Lifesciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.93%1.35B | 6.98%1.39B | 9.50%1.6B | 11.56%6B | 67.71%2.26B | -5.73%1.24B | -5.71%1.3B | 8.83%1.46B | 2.86%5.38B | 1.40%1.35B |
| Operating revenue | 8.93%1.35B | 6.98%1.39B | 9.50%1.6B | 11.56%6B | 67.71%2.26B | -5.73%1.24B | -5.71%1.3B | 8.83%1.46B | 2.86%5.38B | 1.40%1.35B |
| Cost of revenue | 4.91%262.9M | 11.05%285.3M | 17.03%385.6M | 27.71%1.38B | 152.97%652.4M | -1.26%250.6M | -4.64%256.9M | 10.09%329.5M | -13.49%1.08B | -16.67%257.9M |
| Gross profit | 9.94%1.09B | 5.97%1.1B | 7.30%1.21B | 7.51%4.63B | 47.54%1.61B | -6.80%992.8M | -5.97%1.04B | 8.47%1.13B | 7.99%4.3B | 6.88%1.09B |
| Operating expense | 11.61%697.2M | 10.59%723.4M | 11.10%774.9M | 15.27%2.9B | 56.98%1.01B | 2.26%624.7M | -0.86%654.1M | 16.46%697.5M | 4.84%2.51B | -2.07%643.2M |
| Selling and administrative expenses | 10.34%421.4M | 9.84%450.8M | 12.24%489.7M | 16.39%1.82B | 60.27%658.7M | 1.22%381.9M | 0.34%410.4M | 17.82%436.3M | 4.95%1.57B | -3.07%411M |
| Research and development costs | 4.37%253.4M | 11.86%272.6M | 9.19%285.2M | 13.39%1.07B | 51.16%351M | 3.94%242.8M | -2.83%243.7M | 14.26%261.2M | 4.66%945.2M | -0.26%232.2M |
| Other operating expenses | --22.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 7.12%394.3M | -1.90%377.2M | 1.18%437.7M | -3.39%1.73B | 33.97%599.1M | -18.97%368.1M | -13.54%384.5M | -2.35%432.6M | 12.76%1.79B | 23.06%447.2M |
| Net non-operating interest income expense | 60.93%24.3M | 70.33%15.5M | 91.86%16.5M | 204.29%49.6M | 112.66%16.8M | 118.84%15.1M | 911.11%9.1M | 1,333.33%8.6M | 1,730.00%16.3M | 1,480.00%7.9M |
| Non-operating interest income | 60.93%24.3M | 70.33%15.5M | ---- | 89.30%67.2M | --34.4M | --15.1M | --9.1M | ---- | 104.02%35.5M | ---- |
| Non-operating interest expense | ---- | ---- | ---- | -8.33%17.6M | ---- | ---- | ---- | ---- | 4.35%19.2M | ---- |
| Total other finance cost | ---- | ---- | -91.86%-16.5M | ---- | ---- | ---- | ---- | ---8.6M | ---- | ---- |
| Other net income (expense) | -459.09%-15.8M | 94.85%-6.1M | -5.16%-44.8M | -372.70%-180.1M | -647.62%-23M | 108.16%4.4M | -720.42%-118.5M | -468.00%-42.6M | -132.79%-38.1M | -66.13%4.2M |
| Gain on sale of security | ---- | ---- | ---- | 526.09%9.8M | ---- | ---- | ---- | ---- | -121.30%-2.3M | ---- |
| Special income (charges) | -1,886.36%-43.7M | 93.31%-8.1M | -13.57%-50.2M | -427.10%-194.5M | -715.91%-27.1M | 95.76%-2.2M | -750.54%-121M | -952.38%-44.2M | -135.65%-36.9M | -60.00%4.4M |
| -Less：Restructuring and merger&acquisition | --32.9M | --0 | 5,800.00%41.3M | -136.14%-9M | -71.90%17.2M | --0 | -28.71%-26.9M | 124.14%700K | 120.06%24.9M | 438.12%61.2M |
| -Less:Other special charges | 390.91%10.8M | -94.52%8.1M | -79.54%8.9M | 1,595.83%203.5M | 115.09%9.9M | -96.58%2.2M | 6,330.43%147.9M | 512.68%43.5M | -41.75%12M | -1,023.94%-65.6M |
| Other non- operating income (expenses) | 322.73%27.9M | -20.00%2M | 237.50%5.4M | 318.18%4.6M | -371.43%-5.7M | 430.00%6.6M | 66.67%2.5M | 1,500.00%1.6M | -42.11%1.1M | 600.00%2.1M |
| Income before tax | 3.92%402.8M | 40.53%386.6M | 2.71%409.4M | -9.58%1.6B | 29.09%592.9M | -4.84%387.6M | -40.80%275.1M | -8.60%398.6M | 3.84%1.77B | 22.06%459.3M |
| Income tax | -22.77%40.7M | -3.35%20.2M | 0.52%58.4M | -19.06%198.7M | 32.02%80.4M | -17.40%52.7M | -64.15%20.9M | -7.04%58.1M | 23.43%245.5M | 48.54%60.9M |
| Net income | 699.95%3.07B | 19.48%365M | 3.08%351M | -8.05%1.4B | -7.20%369.7M | 11.70%383.7M | -24.83%305.5M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M |
| Net income continuous Operations | 8.12%362.1M | 44.14%366.4M | 3.08%351M | -8.05%1.4B | 28.64%512.5M | -2.50%334.9M | -37.45%254.2M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M |
| Net income discontinuous operations | 5,447.75%2.71B | -102.73%-1.4M | ---- | ---- | ---- | --48.8M | --51.3M | ---- | ---- | ---- |
| Minority interest income | -16.67%-1.4M | 18.75%-1.3M | -900K | -3M | -200K | -1.2M | -1.6M | 0 | 0 | 0 |
| Net income attributable to the parent company | 697.82%3.07B | 19.28%366.3M | 3.35%351.9M | -7.85%1.4B | -7.15%369.9M | 12.05%384.9M | -24.43%307.1M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 697.82%3.07B | 19.28%366.3M | 3.35%351.9M | -7.85%1.4B | -7.15%369.9M | 12.05%384.9M | -24.43%307.1M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M |
| Basic earnings per share | 715.87%5.14 | 19.61%0.61 | 3.57%0.58 | -6.10%2.31 | -6.15%0.61 | 14.55%0.63 | -21.54%0.51 | -6.67%0.56 | 2.07%2.46 | 20.37%0.65 |
| Diluted earnings per share | 714.29%5.13 | 22.00%0.61 | 3.57%0.58 | -5.74%2.3 | -6.15%0.61 | 14.55%0.63 | -23.08%0.5 | -5.08%0.56 | 2.52%2.44 | 22.64%0.65 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data